DESMOPRESSIN ACETATE injection, solution Spojené štáty - angličtina - NLM (National Library of Medicine)

desmopressin acetate injection, solution

northstar rxllc - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - hemophilia a: desmopressin acetate injection 4 mcg/ml is indicated for patients with hemophilia a with factor viii coagulant activity levels greater than 5%. desmopressin acetate injection will often maintain hemostasis in patients with hemophilia a during surgical procedures and postoperatively when administered 30 minutes prior to scheduled procedure. desmopressin acetate injection will also stop bleeding in hemophilia a patients with episodes of spontaneous or trauma-induced injuries such as hemarthroses, intramuscular hematomas or mucosal bleeding. in certain clinical situations, it may be justified to try desmopressin acetate injection in patients with factor viii levels between 2% to 5%; however, these patients should be carefully monitored. von willebrand’s disease (type i): desmopressin acetate injection 4 mcg/ml is indicated for patients with mild to moderate classic von willebrand’s disease (type i) with factor viii levels greater than 5%. desmopressin acetate injection will often ma

DESMOPRESSIN ACETATE tablet Spojené štáty - angličtina - NLM (National Library of Medicine)

desmopressin acetate tablet

northwind pharmaceuticals, llc - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - central diabetes insipidus desmopressin acetate tablets are indicated as antidiuretic replacement therapy in the management of central diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. desmopressin acetate is ineffective for the treatment of nephrogenic diabetes insipidus. patients were selected for therapy based on the diagnosis by means of the water deprivation test, the hypertonic saline infusion test, and/or response to antidiuretic hormone. continued response to desmopressin acetate can be monitored by measuring urine volume and osmolality. primary nocturnal enuresis desmopressin acetate tablets are indicated for the management of primary nocturnal enuresis. desmopressin acetate may be used alone or as an adjunct to behavioral conditioning or other non-pharmacologic intervention. desmopressin acetate tablets are contraindicated in individuals with known hypersensitivity to desmopressin acetate or to any of the comp

Desmospray Desmopressin Nasal Spray 10mcg/0.1ml Malta - angličtina - Medicines Authority

desmospray desmopressin nasal spray 10mcg/0.1ml

ferring ireland limited united drug house, magna drive magna business park, citywest road dublin 24 , ireland - desmopressin acetate - nasal spray - desmopressin acetate 10 µg - pituitary and hypothalamic hormones and analogues

NOCTIVA- desmopressin acetate spray, metered Spojené štáty - angličtina - NLM (National Library of Medicine)

noctiva- desmopressin acetate spray, metered

avadel specialty pharmaceuticals, llc - desmopressin acetate (unii: xb13hyu18u) (desmopressin - unii:enr1llb0fp) - desmopressin acetate 0.83 ug - noctiva is indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. nocturnal polyuria was defined in the noctiva clinical trials as nighttime urine production exceeding one-third of the 24-hour urine production. before starting noctiva: - evaluate the patient for possible causes for the nocturia, including excessive fluid intake prior to bedtime, and optimize the treatment of underlying conditions that may be contributing to the nocturia. - confirm the diagnosis of nocturnal polyuria with a 24-hour urine collection, if one has not been obtained previously. limitation of use : noctiva has not been studied in patients less than 50 years of age. noctiva is contraindicated in patients with the following conditions due to an increased risk of severe hyponatremia: - hyponatremia or a history of hyponatremia [see warnings and precautions (5.1)] - polydipsia - primary nocturnal enuresis [see use in specific populations (8.4)] - concomitant use with

Desmopressin Nasal Spray Malta - angličtina - Medicines Authority

desmopressin nasal spray

ferring pharmaceuticals limited - desmopressin acetate 0.1 mg/ml - nasal spray, solution

DDAVP Desmopressin 100 micrograms/ml Nasal drops, solution Írsko - angličtina - HPRA (Health Products Regulatory Authority)

ddavp desmopressin 100 micrograms/ml nasal drops, solution

ferring ireland ltd - desmopressin acetate - nasal drops, solution - 100 microgram(s)/millilitre - vasopressin and analogues; desmopressin

DDAVP/Desmopressin Intranasal Solution Malta - angličtina - Medicines Authority

ddavp/desmopressin intranasal solution

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - desmopressin acetate - solution - desmopressin acetate 0.01 % (v/v) - pituitary and hypothalamic hormones and analogues

MINIRIN SOLUTION Izrael - angličtina - Ministry of Health

minirin solution

ferring pharmaceuticals ltd - desmopressin acetate - nasal solution - desmopressin acetate 0.1 mg/ml - desmopressin - desmopressin - treatment of cranial diabetes insipidus. treatment of post hypophysectomy polyuria-polydypsia.

MINIRIN MELT 60 MCG Izrael - angličtina - Ministry of Health

minirin melt 60 mcg

ferring pharmaceuticals ltd - desmopressin as acetate - tablets soluble - desmopressin as acetate 60 mcg - desmopressin - desmopressin - nocturnal enuresis.

MINIRIN MELT 120 MCG Izrael - angličtina - Ministry of Health

minirin melt 120 mcg

ferring pharmaceuticals ltd - desmopressin as acetate - tablets soluble - desmopressin as acetate 120 mcg - desmopressin - desmopressin - nocturnal enuresis.